David Fajgenbaum
David Fajgenbaum[edit | edit source]
David C. Fajgenbaum is an American immunologist, researcher, and author known for his groundbreaking work in the field of Castleman disease, a rare and complex group of disorders characterized by lymph node enlargement and a variety of systemic symptoms. He is also a prominent figure in the field of rare disease research and advocacy.
Early Life and Education[edit | edit source]
David Fajgenbaum was born in Raleigh, North Carolina. He attended Georgetown University, where he played football and graduated with a degree in Human Sciences. He later pursued a medical degree at the Perelman School of Medicine at the University of Pennsylvania. During his time in medical school, Fajgenbaum was diagnosed with Castleman disease, which significantly influenced his career path and research focus.
Career[edit | edit source]
Fajgenbaum is an Assistant Professor of Medicine in Translational Medicine and Human Genetics at the University of Pennsylvania. He is also the co-founder and Executive Director of the Castleman Disease Collaborative Network (CDCN), an organization dedicated to accelerating research and treatment for Castleman disease. His work has been instrumental in identifying new treatment strategies for the disease, including the repurposing of existing drugs.
Research Contributions[edit | edit source]
Fajgenbaum's research has focused on understanding the pathophysiology of Castleman disease and identifying potential therapeutic targets. He has published numerous articles in leading medical journals and has been a vocal advocate for patient-centered research approaches. His efforts have led to significant advancements in the understanding and treatment of Castleman disease.
Personal Life[edit | edit source]
David Fajgenbaum's personal battle with Castleman disease has been a driving force behind his professional achievements. His experiences as a patient have provided him with unique insights into the challenges faced by individuals with rare diseases. Fajgenbaum is also the author of the memoir "Chasing My Cure: A Doctor's Race to Turn Hope Into Action," which chronicles his journey from patient to researcher and advocate.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
